Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.

Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.



СІМЕЙНІ ЛІКАРІ ТА ТЕРАПЕВТИ
день перший
день другий

НЕВРОЛОГИ, НЕЙРОХІРУРГИ, ЛІКАРІ ЗАГАЛЬНОЇ ПРАКТИКИ, СІМЕЙНІ ЛІКАРІ

КАРДІОЛОГИ, СІМЕЙНІ ЛІКАРІ, РЕВМАТОЛОГИ, НЕВРОЛОГИ, ЕНДОКРИНОЛОГИ

СТОМАТОЛОГИ

ІНФЕКЦІОНІСТИ, СІМЕЙНІ ЛІКАРІ, ПЕДІАТРИ, ГАСТРОЕНТЕРОЛОГИ, ГЕПАТОЛОГИ
день перший
день другий

ТРАВМАТОЛОГИ

ОНКОЛОГИ, (ОНКО-ГЕМАТОЛОГИ, ХІМІОТЕРАПЕВТИ, МАМОЛОГИ, ОНКО-ХІРУРГИ)

ЕНДОКРИНОЛОГИ, СІМЕЙНІ ЛІКАРІ, ПЕДІАТРИ, КАРДІОЛОГИ ТА ІНШІ СПЕЦІАЛІСТИ

ПЕДІАТРИ ТА СІМЕЙНІ ЛІКАРІ

АНЕСТЕЗІОЛОГИ, ХІРУРГИ

"Emergency medicine" №2(97), 2019

Back to issue

Sevoflurane consumption over the low-flow or minimal-flow anesthesia during thyroid surgery in thyrotoxicosis patients

Authors: S.O. Tarasenko(1), O.A. Tovkai(1), S.O. Dubrov(2), M.V. Kunatovskiy(1), O.O. Yefimova(1), V.L. Rudenko(1)
(1) — Ukrainian Research and Practical Centre of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv, Ukraine
(2) — Bogomolets National Medical University, Kyiv, Ukraine

Categories: Medicine of emergency

Sections: Medical forums

print version

Background. The purpose was to study the consumption of an inhalation anesthetic and to compare of clinical and economic components during using of the low-flow anesthesia or the minimal flow anesthesia by sevoflurane in hyperthyroidism patients undergoing thyroidectomy. Materials and methods. All patients were divided into 2 groups: in a group of “sevoflurane balanced analgesia” (BA-S) were included 35 patients, whom were used the minimal flow anesthesia (MFA) with fresh gas flow (FGF) = 400 ml/min. In a group “sevoflurane control group” (C-S) were included 46 patients, the low-flow anesthesia (LFA) with the fresh gas flow (FGF) = 500 ml/min was used in 25 patients (subgroup C-SLFA), LFA with FGF = 700 ml/min was used in 21 patients (subgroup C-SLFA0.7). We evaluated the consumption of sevoflurane by Dion’s equatione and Biro’s equatione by assessing the vaporizer dial concentration in percent, FGF in liters/minute and time for which the concentration was set in minutes. We calculated the cost of anesthesia as a cost of average doses of sevoflurane and expendable materials that were used during anesthesia. Results. The sevoflurane consumptions by Dion's equatione were 6,25 ± 0,23 ml for the BA-S group, 6,77 ± 0,26 ml for the subgroup of C-SFLA and 8,04 ± 0,32 ml for the subgroup of C-SLFA0,7 and were not significant (p < 0,05) more than in Biro’s equatione, where The sevoflurane consumptions were 5,81 ± 0,24 ml, 6,37 ± 0,27 ml and 7,52 ± 0.34 ml for BA-S, C-SFLA and C-SLFA0,7 subgroups, respectively. Between the values of sevoflurane consumption by Biro’s and Dion’s equationes there is a strong direct correlation on Spearman’s correlation coefficient (rs). For the group of BA-S rs = 0,87, for C-SLFA rs = 0,86, for C-SLFA0,7 rs = 0,84. The sevoflurane consumption was significantly (p = 0,034, the Wilcoxon criterion) lower in the BA-S compared to the control subgroups C-SLFA and C-SLFA0,7.
In the BA-S group MFA has been demonstrated pharmaco-economic benefits, which were amounted to 100,3 ± 4,1 UAH and 107,8 ± 4,0 UAH for both equationes, Biro’s and Dion’s, respectively. These rates were significantly (p = 0,029, the Wilcoxon criterion) lower in the BA-S group compared to subgroups C-SLFA and C-SLFA0,7. In our point of view, Dion’s equatione for assessment of volatile anesthetic consumption reflects sevoflurane consumption largely, that Biro’s equatione, because Dion’s equatione takes into account the sum of products of each segment anesthesia and minimal changes in components, such as the vaporizer dial concentration in percent, FGF and duration which the concentration was set up. There is the final formula for fluid sevoflurane consumption (ml) = 0,05457 × (Pn × Fn × Tn), where Pn, Fn, Tn — the sum of products of sevoflurane vaporizer dial concentration (P), the fresh gas flow (F) and the duration of use of these parameters (T) under anesthesia: ((P1 × F1 × T1) + (P2 × F2 × T2) ... n). When applying the MFA greater influence on sevoflurane consumption has the fresh gas flow than the vaporizer dial concentration, whereas with an increase of FGF to 500–700 ml/min greater influence on consumption has anesthetic vaporizer dial concentration than FGF. The MFA with FGF = 400 ml/min has significantly less the cost of anesthesia, than the LFA with 500–700 ml/min. Conclusions. Both, Biro’s metod and Dion’s equatione have been allowed to estimate the sevoflurane anesthesia consumption. Between the equationes there are a strong positive correlation, there is no significant difference between the results of the calculations. The sevoflurane consumption was significantly (p < 0,05) lower under MFA with FGF = 400 ml/min, compared with LFA with FGF = 500 ml/min and 700 ml/min.


Bibliography

1. Biro P. Calculation of volatile anaesthetics consumption from agent concentration and fresh gas flow // Acta anaesthesiologica Scandinavica, 2014;58(8):968-972. doi: 10.1111/aas.12374.
2. Dion P. The cost of anaesthetic vapours // Canadian Journal of Anaesthesia July 1992, Volume 39, Issue 6, pp 633-633.
3. Дубров С.О. Інгаляційна анестезія севофлураном при хірургії щитоподібної залози: низькопотокова або мінімально-потокова анестезія? / С.О. Дубров, С.О. Тарасенко, В.А. Мазніченко // Клінічна ендокринологія та ендокринна хірургія. — 2016. — № 3. — С. 38-48. https://doi.org/10.24026/1818-1384.3(55).2016.77511

Back to issue